Heather Olson | Medical Services
Specialties
Programs & Services
- Brain Development and Genetics Clinic
- CDKL5 Clinic
- Epilepsy Center
- Epilepsy Genetics Program
- Fetal-Neonatal Neurology Program
- Neurogenetics and Neurodevelopment Program
- Neurology
Languages
- English
Heather Olson | Education
Medical School
Mayo Medical School
2006, Rochester, NY, US
Undergraduate School
Colby College
2001, Waterville, ME, US
Residency
Pediatrics
Boston Combined Residency Program (BCRP)
2008, Boston, MA, US
Residency
Pediatric Neurology
Boston Children's Hospital
2011, Boston, MA, US
Fellowship
Epilepsy; Clinical Neurophysiology
Boston Children's Hospital
2012, Boston, MA, US
Fellowship
Neurogenetics; Epilepsy Genetics
Boston Children's Hospital
2013, Boston, MA, US
Graduate School
MS, Epidemiology
Harvard T.H. Chan School of Public Health
2016, Boston, MA
Heather Olson | Certifications
- American Board of Psychiatry and Neurology (Child and Adolescent Neurology)
- American Board of Psychiatry and Neurology (Epilepsy)
Heather Olson | Professional History
I am a child neurologist with expertise in Epilepsy, Clinical Neurophysiology, Neurogenetics, and Fetal/Neonatal Neurology. I am medical director of Epilepsy Genetics, and I am director and co-founder of the CDKL5 Clinic at Boston Children’s Hospital. I additionally see general neurology patients with our amazing nurse practitioners at the Peabody Satellite.
I have extensive experience in clinical care and research for populations of patients with infantile-onset developmental and epileptic encephalopathies, and I lead a clinical research team at Boston Children’s Hospital. I completed a career development award from National Institute of Neurological Disorders and Stroke titled “Diagnosis and genotype-phenotype correlations in early life epilepsy and CDKL5 Deficiency Disorder.” My locally, nationally and internationally collaborative research aims to advance clinical and translational research in CDKL5 Deficiency Disorder and other infantile-onset epilepsy syndromes.
I have experience in observational clinical studies, clinical trials, and translational research. My recent work has helped to characterize genotype-phenotype correlations in infantile-onset epilepsies, and to establish Natural History and outcome measures for this population. I have served as principal investigator for industry-sponsored clinical trials and I wrote my own investigator initiated trial with support from the National Institute of Neurological Disorders and Stroke Clinical Trials Methodology Course.